The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells

American Journal of Physiology - Renal Physiology

Volumn 287, Issue 3 56-3, 2004, Pages

  Cutillas, Pedro R ^a,b   Chalkley, Robert J ^d   Hansen, Kirk C ^d   Cramer, Rainer ^a,b   Norden, Anthony G W ^c   Waterfield, Mike D ^a,b   Burlingame, Alma L ^d   Unwin, Robert J ^b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Kidney; Mass spectroscopy; Proteomics; Urine

Indexed keywords

APOLIPOPROTEIN; CARRIER PROTEIN; COMPLEMENT; CYTOKINE; CYTOTOXIC FACTOR; POLYPEPTIDE; PROTEOME; RECEPTOR; VITAMIN;

ADULT; ARTICLE; CASE REPORT; CLC5 GENE; CONTROLLED STUDY; DENT DISEASE; ENDOCYTOSIS; FANCONI RENOTUBULAR SYNDROME; GEL ELECTROPHORESIS; GENE; GENE MUTATION; HUMAN; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN TRANSPORT; PROTEOMICS; URINALYSIS; URINARY TRACT; X CHROMOSOME LINKED DISORDER;

EID: 4143107797     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00018.2004     Document Type: Article

References (53)

1. Batuman V, Verroust PJ, Navar GL, Kaysen JH, Goda FO, Campbell WC, Simon E, Pontillon F, Lyles M, Bruno J, and Hammond TG. Myeloma light chains are ligands for cubilin (gp280). Am J Physiol Renal Physiol 275: F246-F254, 1998.
2. Benvenuti S, Cramer R, Quinn CC, Bruce J, Zvelebil M, Corless S, Bond J, Yang A, Hockfield S, Burlingame AL, Waterfield MD, and Jat PS. Differential proteome analysis of replicative senescence in rat embryo fibroblasts. Mol Cell Proteomics 1 280-292, 2002.
3. 12. Am J Physiol Renal Physiol 282: F408-F416, 2002.
4. Christensen EI and Birn H. Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol 3: 256-266, 2002.
5. Christensen EI, Devuyst O, Dom G, Nielsen R, Van der SP, Verroust P, Leruth M, Guggino WB, and Courtoy PJ. Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc Natl Acad Sci USA 100: 8472-8477, 2003.
6. Christensen EI, Moskaug JO, Vorum H, Jacobsen C, Gundersen TE, Nykjaer A, Blomhoff R, Willnow TE, and Moestrup SK. Evidence for an essential role of megalin intransepithelial transport of retinol. J Am Soc Nephrol 10: 685-695, 1999.
7. Cox JP, Yamamoto K, Christie PT, Wooding C, Feest T, Flinter FA, Goodyer PR, Leumann E, Neuhaus T, Reid C, Williams PF, Wrong O, and Thakker RV. Renal chloride channel, CLCN5, mutations in Dent's disease. J Bone Miner Res 14: 1536-1542, 1999.
8. Cui S, Verroust PJ, Moestrup SK, and Christensen EI. Megalin/gp330 mediates uptake of albumin in renal proximal tubule. Am J Physiol Renal Fluid Electrolyte Physiol 271: F900-F907, 1996.
9. Cutillas PR, Norden AG, Cramer R, Burlingame AL, and Unwin RJ. Detection and analysis of urinary peptides by on-line liquid chromatography and mass spectrometry: application to patients with renal Fanconi syndrome. Clin Sci 104: 483-490, 2003.
10. Gerbaud V, Pignol D, Loret E, Bertrand JA, Berland Y, Fontecilla-Camps JC, Canselier JP, Gabas N, and Verdier JM. Mechanism of calcite crystal growth inhibition by the N-terminal undecapeptide of lithostathine. J Biol Chem 275: 1057-1064, 2000.
11. Gharbi S, Gaffney P, Yang A, Zvelebil MJ, Cramer R, Waterfield MD, and Timms JF. Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol Cell Proteomics 1: 91-98, 2002.
12. Goldberg HA and Warner KJ. The staining of acidic proteins on polyacrylamide gels: enhanced sensitivity and stability of "Stains- all" staining in combination with silver nitrate. Anal Biochem 251: 227-233, 1997.
13. Gunther W, Piwon N, and Jentsch TJ. The ClC-5 chloride channel knock-out mouse-an animal model for Dent's disease. Pflügers Arch 445: 456-462, 2003.
14. Gygi SP, Corthals GL, Zhang Y, Rochon Y, and Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc Natl Acad Sci USA 97: 9390-9395, 2000.
15. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, and Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17: 994-999, 1999.
16. Hammerman MR and Rogers S. Distribution of IGF receptors in the plasma membrane of proximal tubular cells. Am J Physiol Renal Fluid Electrolyte Physiol 253: F841-F847, 1987.
17. 13C-isotopte-coded affinity tag and multidimensional chromatography. Mol Cell Proteomics 2: 299-314, 2003.
18. Hession C, Decker JM, Sherblom AP, Kumar S, Yue CC, Mattaliano RJ, Tizard R, Kawashima E, Schmeissner U, Heletky S, Chow EP, Burne CA, Shaw A, and Muchmore AV. Uromodulin (Tamm-Horsfall glycoprotein): a renal ligand for lymphokines. Science 237: 1479-1484, 1987.
19. Hilpert J, Nykjaer A, Jacobsen C, Wallukat G, Nielsen R, Moestrup SK, Haller H, Luft FC, Christensen EI, and Willnow TE. Megalin antagonizes activation of the parathyroid hormone receptor. J Biol Chem 274: 5620-5625, 1999.
20. Hirschberg R and Ding H. Growth factors and acute renal failure. Semin Nephrol 18: 191-207, 1998.
21. Ibrahim HN, Rosenberg ME, and Hostetter TH. Proteinuria. In: The Kidney, edited by Seldin DW and Giebish G. Philadelphia, PA: Lippincott Williams and Wilkins, 2000, p. 2269-2294.
22. Isogai Z, Ono RN, Ushiro S, Keene DR, Chen Y, Mazzieri R, Charbonneau NL, Reinhardt DP, Rifkin DB, and Sakai LY. Latent transforming growth factor β-binding protein I interacts with fibrillin and is a microfibril- associated protein (Abstract). J Biol Chem 278: 2750, 2003.
23. Iwai N, Matsunaga M, Kita T, Tei M, and Kawai C. Detection of low molecular kininogen messenger RNA in human kidney. J Hypertens Suppl 6: 399-400, 1988.
24. Kajikawa K, Yasui W, Sumiyoshi H, Yoshida K, Nakayama H, Ayhan A, Yokozaki H, Ito H, and Tahara E. Expression of epidermal growth factor in human tissues. Immunohistochemical and biochemical analysis. Virchows Arch A Pathol Anat Histopathol 418: 27-32, 1991.
25. Kaufmann M, Muff R, Stieger B, Biber J, Murer H, and Fischer J. Apical and basolateral parathyroid hormone receptors in rat renal cortical membranes. Endocrinology 134: 1173-1178, 1994.
26. Kingdon EJ, Knight CJ, Dustan K, Irwin AG, Thomas M, Powis SH, Burns A, Hilson AJ, and Black CM. Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment. Rheumatology (Oxf) 42: 26-33, 2003.
27. Kleinman JG, Beshensky A, Worcester EM, and Brown D. Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int 47: 1585-1596, 1995.
28. Kozyraki R, Fyfe J, Verroust PJ, Jacobsen C, Dautry-Varsat A, Gburek J, Willnow TE, Christensen EI, and Moestrup SK. Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia. Proc Natl Acad Sci USA 98: I2491-I2496, 2001.
29. Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, Rigden SP, Wrong O, Jentsch TJ, Craig IW, and Thakker RV. A common molecular basis for three inherited kidney stone diseases. Nature 379: 445-449, 1996.
30. Mann M, Hendrickson RC, and Pandey A. Analysis of proteins and proteomes by mass spectrometry. Annu Rev Biochem 70: 437-473, 2001.
31. Marino M, Zheng G, Chiovato L, Pinchera A, Brown D, Andrews D, and McCluskey RT. Role of megalin (gp330) in transcytosis of thyroglobulin by thyroid cells. A novel function in the control of thyroid hormone release. J Biol Chem 275: 7125-7137, 2000.
32. Moorhead JF, Chan MK, El Nahas M, and Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2: 1309-1311, 1982.
33. Morita Y, Ikeguchi H, Nakamura J, Hotta N, Yuzawa Y, and Matsuo S. Complement activation products in the urine from proteinuric patients. J Am Soc Nephrol 11: 700-707, 2000.
34. Naaby-Hansen S, Waterfield MD, and Cramer R. Proteomics-post-genomic cartography to understand gene function. Trends Pharmacol Sci 22: 376-384, 2001.
35. Nangaku M, Pippin J, and Couser WG. Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. J Am Soc Nephrol 10: 2323-2331, 1999.
36. Norden AG, Lapsley M, Lee PJ, Pusey CD, Scheinman SJ, Tam FW, Thakker RV, Unwin RJ, and Wrong O. Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int 60: 1885-1892, 2001.
37. Norden AG, Scheinman SJ, Deschodt-Lanckman MM, Lapsley M, Nortier JL, Thakker RV, Unwin RJ, and Wrong O. Tubular proteinuria defined by a study of Dent's (CLCN5 mutation) and other tubular diseases. Kidney Int 57: 240-249, 2000.
38. 3. Cell 96: 507-515, 1999.
39. Oh Y, Nagalla SR, Yamanaka Y, Kim HS, Wilson E, and Rosenfeld RG. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II. J Biol Chem 271: 30322-30325, 1996.
40. Ong AC, Jowett TP, Moorhead JF, and Owen JS. Human high density lipoproteins stimulate endothelin-1 release by cultured human renal proximal tubular cells. Kidney Int 46: 1315-1321, 1994.
41. Ong SE, Foster LJ, and Mann M. Mass spectrometric-based approaches in quantitative proteomics. Methods 29: 124-130, 2003.
42. Orlando RA, Rader K, Authier F, Yamazaki H, Posner BI, Bergeron JJ, and Farquhar MG. Megalin is an endocytic receptor for insulin. J Am Soc Nephrol 9: 1759-1766, 1998.
43. - channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 408: 369-373, 2000.
44. Poumarat JS, Houillier P, Rismondo C, Roques B, Lazar G, Paillard M, and Blanchard A. The luminal membrane of rat thick limb expresses AT receptor and aminopeptidase activities. Kidney Int 62: 434-445, 2002.
45. Shen Y, Zhao R, Belov ME, Conrads TP, Anderson GA, Tang K, Pasa-Tolic L, Veenstra TD, Lipton MS, Udseth HR, and Smith RD. Packed capillary reversed-phase liquid chromatography with high-performance electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry for proteomics. Anal Chem 73: 1766-1775, 2001.
46. Shevchenko A, Wilm M, Vorm O, and Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68: 850-858, 1996.
47. Sousa MM, Norden AG, Jacobsen C, Willnow TE, Christensen EI, Thakker RV, Verroust PJ, Moestrup SK, and Saraiva MJ. Evidence for the role of megalin in renal uptake of transthyretin. J Biol Chem 275: 38176-38181, 2000.
48. Vakeva A, Laurila P, and Meri S. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction. Lab Invest 67: 608-616, 1992.
49. Wall DB, Kachman MT, Gong SS, Parus SJ, Long MW, and Lubman DM. Isoelectric focusing nonporous silica reversed-phase high-performance liquid Chromatography/electrospray ionization time-of-flight mass spectrometry: a three-dimensional liquid-phase protein separation method as applied to the human erythroleukemia cell-line. Rapid Commun Mass Spectrom 15: 1649-1661, 2001.
50. Wang SS, Devuyst O, Courtoy PJ, Wang XT, Wang H, Wang Y, Thakker RV, Guggino S, and Guggino WB. Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Hum Mol Genet 9: 2937-2945, 2000.
51. Washburn MP, Wolters D, and Yates JR III. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat Biotechnol 19: 242-247, 2001.
52. Wrong OM, Norden AG, and Feest TG. Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 87: 473-493, 1994.
53. Yamamoto K, Cox JPDT, Friedrich T, Christie PT, Bald M, Houtman PN, Lapsley MJ, Patzer L, Tsimaratos M, Van't Hoff WG, Yamaoka K, Jentsch TJ, and Thakker RV. Characterization of renal chloride channel (CLCN5) mutations in Dent's disease. J Am Soc Nephrol 11: 1460-1468, 2003.